Massive study tracks safety of Triple-Threat vaccine in real world
NCT ID NCT07444502
Summary
This study monitored the safety of the Boostagen® vaccine after it was approved for use in Thailand. Over 10,000 people who received the vaccine in regular doctor's offices and clinics were followed to track any side effects. The goal was to understand how safe the vaccine is for a large, diverse population in real-world conditions, including pregnant women and their babies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TETANUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
BioNet-Asia Co., Ltd.
Bangkok, 10260, Thailand
Conditions
Explore the condition pages connected to this study.